ESH Video

ESH-EBMT-EHA-IPIG 3rd Translational Research Conference: Bone Marrow Failure and Leukaemia Predisposition Syndromes

ESH-EBMT-EHA-IPIG 3rd Translational Research Conference: Bone Marrow Failure and Leukaemia Predisposition Syndromes
November 15 - November 17, 2024 - Paris, France - #ESHBMFS2024
Chairs : Carmem Bonfim, Tim Brümmendorf, Antonio Risitano, Sharon Savage

Information

ESH-EBMT-EHA-IPIG 3rd Translational Research Conference
Bone Marrow Failure and Leukaemia Predisposition Syndromes

Save the date: November 15-17, 2024

Paris, France

Chairpersons: Carmem Bonfim, Tim Brümmendorf, Antonio Risitano, Sharon Savage
Scientific Committee: Beatrice Drexler, Carlo Dufour, Morag Griffin, Régis Peffault de Latour

with the support of the Severe Aplastic Anaemia Working Party of the EBMT, the EHA SWG on Granulocyte and Bone Marrow Failures and the International PNH Interest Group

#ESHBMFS2024

 

REGISTRATION & ABSTRACT SUBMISSION
ARE OPEN!

 

 

ABOUT THE CONFERENCE:

The ESH-EBMT-EHA-IPIG 3rd Translational Research Conference: Bone Marrow Failure and Leukaemia Predisposition Syndromes will be of particular value for clinicians and non- clinical scientists, M.D. and Ph.D. of all ages interested in the biology, pathophysiology, diagnosis and treatment of bone marrow failure syndromes (BMFS) and leukaemia predisposition syndromes. We will not only discuss the standard of care in acquired but also inherited BMFS occurring in adult and paediatric patients, but particularly focus on new underlying principles and evolving new treatment strategies.
In good tradition of ESH, we will put special effort on low threshold exchange between young scientists and experts in the field, as well as between clinicians and basic scientists. Meet-the-experts workshop as well as poster walks will allow to highlight topics of special attention and to enable further in-depth exchange. Our dedicated faculty will secure the highest standard of both clinical, translational and basic research.

LEARNING OBJECTIVES:
Upon completion of this CME activity, participants will:
– Improve understanding of the stem cell biology of BMF, from genotoxic stress, inflammaging to failure
– Acquire knowledge of recent advances in Fanconi Anaemia, Ribosome diseases and telomere biology disorder
– Gain insight into novel therapeutics of Paroxysmal Nocturnal Haemoglobinuria and idiopathic Aplastic Anaemia, including knowledge of complement cascade, the current developmental status of various targeted drugs and of novel antibody-based and small molecules based immunotherapeutic approaches, and their promise for future clinical application
– Acquire an overview of emerging approaches and new challenges such as genetic editing of haemopoietic stem cells, single cell RNA sequencing in haemopoiesis and genetic predisposition for myeloid malignancies.

SCIENTIFIC TOPICS:
– Stem cell biology
– Inherited predisposition to leukaemia
– Constitutional marrow failure 2
– Constitutional marrow failure 3: telomere biology diseases and others…
– AA & PNH: 1. Pathophysiology and diagnosis
– AA & PNH: 2. CHIP and clonal evolution in BMFS
– Treatment of aplastic anaemia
– Treatment of paroxysmal nocturnal haemoglobinuria
– Expanding areas in BMFS

THE PROGRAMME WILL INCLUDE:
– Plenary Sessions
– Panel Discussions
– Roundtable
– Poster Walks
– Meet the Expert Sessions
– Brief Oral Communications

 

 

 

Programme

CLICK HERE to access the scientific programme.

Abstract submission

DEADLINE FOR SUBMISSION OF ABSTRACTS FOR BRIEF ORAL COMMUNICATIONS OR POSTER PRESENTATIONS: August 25th, 2024

CLICK HERE TO SUBMIT YOUR ABSTRACT!

Abstracts guidelines:
– Your abstract has to be structured (eg Objectives, Methods, Results, Conclusions)
– Maximum number of words: 500
– Your abstract will be submitted to the peer review procedure.
The following file types may be uploaded: HTML document (*.htm), HTML document (*.html), JPEG image (*.jpg), GIF image (*.gif), or PNG image (*.png).

We accept “encore” abstract.

Presentation of data at this conference will not jeopardize acceptance of the same at the following ASH congress.

Symposia

Accommodation

Venue

Espace Saint-Martin,

199bis Rue Saint-Martin,

75003 Paris, FRANCE

Corporate partners

Scholarships

Workshop

Educational Grants

Registration

REGISTRATION IS OPEN!

 

The registration fee for the ESH-EBMT-EHA-IPIG 3rd Translational Research Conference: Bone Marrow Failure and Leukaemia Predisposition Syndromes is:
– 600€ for fully trained
– 300€ for in-training *
– 300€ Allied Health Professionals
– 600€ for Corporate
*A proof will be requested to confirm your status.

 

ESH is pleased to offer BSH, DGHO and PTHiT Members a 20% discount on the conference registration fees.

 

This fee includes:
– Your seat in the Conference Room
– The conference materials,
– Welcome cocktail, luncheons, refreshments throughout the conference.
Your seat in the conference will be definitively reserved upon receipt of your fee.

 

Cancellation policy of registration fee:
In case of cancellation, up until two months prior to the beginning of the meeting, your registration fee will be reimbursed in full (less bank charges). If the cancellation is notified between 60 to 15 days prior to the beginning of the meeting, 50% of the registration fee will be reimbursed (less bank charges). Cancellations notified 15 days before the meeting will not be reimbursed. For credit card payments please register on-line first. Please note that ESH can accept VISA and MASTERCARD/EUROCARD.

Register Here